Britain’s FTSE 100 index is seen opening 32 points lower at 5,828 on Monday, according to financial bookmakers.
AstraZeneca: AstraZeneca Plc has resumed the U.S. trial of its experimental COVID-19 vaccine after approval by regulators, and Johnson & Johnson is preparing to resume its trial on Monday or Tuesday, the companies said on Friday.
Rio Tinto: Global miner Rio Tinto is seeking court approval to sell its partner’s share of diamonds from a mine in Canada’s Northwest Territories, a filing this week showed, hoping to recover around C$120 million plus legal fees and other costs.
Coca Cola Europeand Partners: Coca-Cola Amatil Ltd said Coca-Cola European Partners offered to buy the Australian bottler for A$9.23 billion ($6.58 billion), in what would be the country’s biggest deal this year.
UK regulators: UK regulators are considering plans to allow banks to start paying dividends again next year, The Times newspaper reported on Monday.
Gold: Gold prices fell to an over one-week low, as the dollar firmed and talks about the new U.S. coronavirus aid package showed no signs of progress.
Oil: Oil extended last week’s losses, falling nearly 2% as a surge in COVID-19 infections in the United States and Europe prompted concern over crude demand, while the prospect of increased supply also hit sentiment.
The UK blue-chip index closed 1.3% higher on Friday, boosted by upbeat Barclays ‘ earnings and rising hopes of a Brexit trade deal before year end, but the blue-chip FTSE 100 still logged its second weekly decline on concerns over fresh coronavirus restrictions.